Denali Therapeutics, Inc. (DNLI)
20.26
+0.58
(+2.95%)
USD |
NASDAQ |
Apr 02, 12:50
Denali Therapeutics Research and Development Expense (TTM) : 418.78M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Protalix Biotherapeutics, Inc. | 19.57M |
| Agenus, Inc. | 79.34M |
| Curis, Inc. | 28.25M |
| Plus Therapeutics, Inc. | 8.379M |
| Windtree Therapeutics, Inc. | 8.129M |